glp 1 snake venom Helped Create Weight-Loss Drugs. What Else Could It Do For Us? Curious how a slow-moving lizard

DECLARATIONS Authors contributions Controlled the study design and preparation of the article: Ciancimino G, Pecorella F, Viscardi SM, La Mantia C, Caserta A, Pennisi G, Petta S Participated in planning and drafting the article: Ciancimino G, Pecorella F, Viscardi SM, La Mantia C, Caserta A, Pennisi G, Petta S Approved the final draft of the article: Ciancimino G, Pecorella F, Viscardi SM, La Mantia C, Caserta A, Pennisi G, Petta S Availability of data and materials Not applicable

However, the actual contribution of such backdoor transport pathways remains elusive

The synergy rationale extrapolates from: (1) documented synergy between GHRH and various GHRPs (particularly GHRP-6) across multiple species and systems, (2) individual characterization of CJC-1295 No DAC showing 49-fold potency enhancement, (3) individual characterization of Ipamorelin showing comparable potency to GHRP-6 but with superior selectivity, and (4) established mechanistic principles of complementary receptor pathway activation

PMC 304654

Sharing a recently published set of practical recommendations by Harvard scientists for patients using highly effective GLP-1 medications